Published in Acta Virol on November 01, 1977
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J Cell Biol (1989) 4.81
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. Am J Transplant (2011) 1.90
Human cell surface proteins selectively assembled into vesicular stomatitis virus virions. Virology (1983) 1.74
Immunodiffusion studies on the reaction of influenza virus with specific antibody and nonspecific serum beta-inhibitor. Acta Virol (1966) 1.45
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant (2012) 1.42
Live donor renal transplantation in Australia 1964-1999: an evolving practice. Intern Med J (2002) 1.39
Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol (1993) 1.34
Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation. J Immunol (1993) 1.25
Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J Gen Virol (2008) 1.21
Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch Virol (2009) 1.16
The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents (2010) 1.15
Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. Acta Virol (1987) 1.10
An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J Virol (1998) 1.09
The use of rivanol treatment for removal from sera of nonspecific inhibitors of enterovirus and reovirus hemagglutination. Am J Epidemiol (1968) 1.07
Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusion-inhibition activity contribute to the protection of mice against lethal infection. J Gen Virol (2007) 1.07
The molecular weight determination of proteins and glycoproteins of RNA enveloped viruses by polyacrylamide gel electrophoresis in SDS. Biochem Biophys Res Commun (1973) 1.03
Renal failure from "glue sniffing". Med J Aust (1981) 1.03
Transcription and replication of the influenza a virus genome. Acta Virol (2000) 1.02
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. Am J Transplant (2009) 1.02
On the relationship between respiratory activity and lipid composition of the yeast cell. Biochim Biophys Acta (1967) 1.00
Evaluation of monoclonal antibodies for subtyping of currently circulating human type A influenza viruses. J Clin Microbiol (1997) 1.00
Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin. Acta Virol (2009) 0.97
Preparation of monoclonal antibodies for the diagnosis of influenza A infection using different immunization protocols. J Immunol Methods (1995) 0.96
Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules. Arch Virol (1993) 0.93
Vibrio alginolyticus peritonitis associated with ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 0.92
The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin. J Gen Virol (2000) 0.91
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. II. Reactivity with rabbit sera against intact virus and purified undissociated haemagglutinin. Acta Virol (1978) 0.90
Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients. Am J Transplant (2013) 0.89
Immunodiffusion reactions with rubella antigens. J Immunol (1968) 0.89
FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study. Am J Transplant (2006) 0.88
Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2. Arch Virol (1988) 0.88
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides. Acta Virol (1979) 0.86
Antibody against Hong Kong influenza viruses in pigs. Acta Virol (1971) 0.86
Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide. Acta Virol (2002) 0.86
Phase II study of single-agent pegylated liposomal doxorubicin HCl (PLD) in metastatic breast cancer after first-line treatment failure. Onkologie (2004) 0.86
Antibody response to natural influenza A2 infection of man as studied by gel double diffusion. Acta Virol (1968) 0.85
PB1-F2 expedition from the whole protein through the domain to aa residue function. Acta Virol (2013) 0.83
Interaction of Staphylococcus aureus with human neutrophils and the down-regulation of TNF receptors. J Immunol (1994) 0.83
Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. Acta Virol (1979) 0.83
Experimental infection of horses with A-equi 2-Miami-1-63 and human A2-Hong Kong 1-68 influenza viruses. I. The course of infection and virus recovery. Acta Virol (1969) 0.83
Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome. Am J Transplant (2007) 0.83
The transmission of donor-derived malignant melanoma to a renal allograft recipient. Clin Transplant (2006) 0.83
Antibody response of guinea pigs and white mice to nucleoprotein component of influenza virus as studied by gel double diffusion. Acta Virol (1968) 0.82
PB1-F2 gene in influenza a viruses of different hemagglutinin subtype. Acta Virol (2006) 0.81
Role of pulmonary blood flow in postpneumonectomy lung growth. J Appl Physiol (1985) (1992) 0.80
Processing and presentation of antigens to class I restricted T lymphocytes. Year Immunol (1990) 0.79
Characterization of influenza A-1983 epidemic strains by polyclonal and monoclonal antibodies and detection of two co-circulating antigenic variants. Acta Virol (1986) 0.79
Trends in development of the influenza vaccine with broader cross-protection. Acta Virol (2010) 0.79
Immunity in latent Herpes simplex virus infection. Acta Virol (2005) 0.79
Thrombotic microangiopathy related to anticardiolipin antibody in a renal allograft. Nephrol Dial Transplant (1999) 0.79
Modulation of HLA-G expression. Neoplasma (2007) 0.79
Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted. Neoplasma (2000) 0.79
Influenza a virus PB1-F2 protein. Acta Virol (2007) 0.79
N-terminal region of the PB1-F2 protein is responsible for increased expression of influenza A viral protein PB1. Acta Virol (2011) 0.79
Monoclonal anti-idiotypic antibodies mimicking the immunodominant epitope of influenza virus haemagglutinin elicit biologically significant immune responses. J Gen Virol (1998) 0.78
Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients. Neoplasma (2009) 0.78
Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines. Leuk Res (2008) 0.78
Dissociation of beta 2-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Mol Immunol (1993) 0.78
The multifaceted effect of PB1-F2 specific antibodies on influenza A virus infection. Virology (2013) 0.78
Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2. Acta Virol (1989) 0.77
Stable inheritance of an HLA-"blank" phenotype associated with a structural mutation in the HLA-A*0301 gene. Tissue Antigens (1996) 0.77
Antigen processing: where tumor-specific T-cell responses begin. J Immunother Emphasis Tumor Immunol (1993) 0.77
Interaction of plasma membranes with influenza virus. II. Release of viral nucleoprotein. Acta Virol (1971) 0.77
Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine. Acta Virol (2005) 0.77
Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection. Acta Virol (1997) 0.77
Antigenic relatedness of alphaherpesviruses isolated from free-living rodents. Acta Virol (1982) 0.77
Rescue of presumptive viral information from human cells by a helper oncovirus. J Gen Virol (1986) 0.76
Impact of blood processing on estimation of soluble HLA-G. Neoplasma (2011) 0.76
Effects of brefeldin A on the expression and transport of influenza A virus haemagglutinin, M1 and M2 proteins within the cell. Acta Virol (1997) 0.76
HLA DPB1 genotyping in Australian aborigines by amplified fragment length polymorphism analysis. Hum Immunol (1993) 0.76
HLA class I variation in Australian aborigines: characterization of allele B*1521. Tissue Antigens (1995) 0.76
Histological standardisation of renal transplant rejection. Aust N Z J Med (1995) 0.75
De novo immunosuppression with mammalian target of rapamycin inhibitors and posttransplantation malignancy in focus. Transplant Proc (2009) 0.75
Experimental infection of horses with A-equi 2-Miami-1-63 and human A2-Hong Kong-1-68 influenza viruses. 3. Immunodiffusion study of the antibody response. Acta Virol (1970) 0.75
Indication and study of antigenic properties of influenza virus internal proteins by means of monoclonal antibodies. Acta Virol (1985) 0.75
Use of Brefeldin A to localize block in intracellular transport of vesicular stomatitis virus G protein on interferon-treated cells. Arch Virol (1992) 0.75
Use of monoclonal antibodies against avian retroviral protein p19 for competitive radioimmunoassay and immunodiffusion. Neoplasma (1983) 0.75
Monoclonal antibody against an antigen selectively assembled into vesicular stomatitis virus virions from HeLa cells. Int J Cancer (1984) 0.75
Vesicular stomatitis virus phenotypically mixed with retroviruses: an efficient detection method. Acta Virol (1983) 0.75
MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy. J Comput Assist Tomogr (1994) 0.75
Reduced expression of HLA-DP antigens on PWM stimulated T lymphocytes in patients suffering from psoriasis vulgaris. Immunobiology (1991) 0.75
[Biology of the influenza viruses]. Bratisl Lek Listy (1983) 0.75
Production of monoclonal antibodies with haemagglutination-inhibition activity to the Skalica strain from the tick-borne encephalitis complex. Acta Virol (1983) 0.75
Purification of tick-borne encephalitis virus by affinity chromatography using monoclonal antibody. Acta Virol (1984) 0.75
[Preparation and use of monoclonal antibodies]. Bratisl Lek Listy (1983) 0.75
Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2. Acta Virol (1991) 0.75
Production and characterization of monoclonal antibodies against avian myeloblastosis virus. Neoplasma (1983) 0.75
Characterization of a monoclonal antibody with CD44 like reactivity. Dis Markers (1992) 0.75
Acute renal failure due to bilateral ureteral hematomas complicating anticoagulant therapy. Nephron (1993) 0.75